MOISTIE CELL PLUS

Manufacturer
Purecell Korea Co., Ltd. | MICELL KOREA CO.,LTD
Effective date
2018-09-29
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 22:56:56

Label at a glance#

ProductMOISTIE CELL PLUS
Active ingredientNIACINAMIDE, ADENOSINE
Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Niacinamide, Adenosine

INACTIVE INGREDIENT SECTION

Water, Glycerin, Butylene Glycol

OTC - PURPOSE SECTION

Skin Protectant - Whitening & Anti-wrinkle

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

keep out or reach of the children


INDICATIONS & USAGE SECTION

1. After cleansing, massage slowly along your face skin's texture. (After cleansing, You can do it after applying your skin softner)
2. Forehead
Massage with proper pressure of the finger from top to bottom in one direction.
3. Chin
Massage with proper pressure of the fingers from top to bottom, or from side to side in one direction.
4. Cheek
Massage the finger at the proper pressure only in one direction from the lower jaw to the upper jaw along the skin's texture.
5. Finish,
with lotion or cream after fever disappears. you can make up. It is usually done in the evening or at night.
6. After the heat is gone, finish with lotion or cream. It is usually done in the evening or at night. (You can use it once a week even if it is used in dermatology)

WARNINGS SECTION

1. Do not use in the following cases(Eczema and scalp wounds)
2.Side Effects
1)Due to the use of this druf if rash, irritation, itching and symptopms of hypersnesitivity occur dicontinue use and consult your phamacisr or doctor
3.General Precautions
1)If in contact with the eyes, wash out thoroughty with water If the symptoms are servere, seek medical advice immediately
2)This product is for exeternal use only. Do not use for internal use
4.Storage and handling precautions
1)If possible, avoid direct sunlight and store in cool and area of low humidity
2)In order to maintain the quality of the product and avoid misuse
3)Avoid placing the product near fire and store out in reach of children

DOSAGE & ADMINISTRATION SECTION

for external use only

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ADENOSINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d676a241-be05-4740-b3ee-1a5f2ed422d2Product name420180615
dd8bd48f-20d6-43c7-b471-3ae872868afaProduct name320180125
d41954ff-bc63-4b2c-aba0-9146707659d7Product name220151117

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
71609-0003-12020-01-31C16284748780-19d75b9d0-bbc0-f424-e053-dadaa90a57ceDrug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71609-0003-1MOISTIE CELL PLUS10 mL in 1 SYRINGE, PLASTICCREAM102

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71609-0003MOISTIE CELL PLUS (NIACINAMIDE, ADENOSINE) CREAM [PURECELL KOREA CO., LTD.]2Legacy NDC, 1 package rows20181010_563605cb-a2c9-5408-e054-00144ff88e88.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
71609-000371609-0003-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
770d8c3a-834b-0bf1-e053-2991aa0a286c563605cb-a2c9-5408-e054-00144ff88e882018-09-29WarningsExact identifier
spl id: 770d8c3a-834b-0bf1-e053-2991aa0a286c
spl set id: 563605cb-a2c9-5408-e054-00144ff88e88

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.